Company news
Albert Labs International Corp. (CSE:ABRT) news
Albert Labs International Corp. news releases on 6ix. Latest, May 2, 2023: Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent…
Press releases & updates
Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology
May 2, 2023
Albert Labs announces Private Placement
April 24, 2023
Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human Trials
March 28, 2023
Albert Labs Validates Global Supply Chain for Controlled Substances
March 15, 2023
Albert Labs signs Letter of Intent (LOI) with iNGENū CRO for First In-Human Clinical Studies
November 17, 2022
Albert Labs provides Corporate Update
October 25, 2022
Albert Labs International Corp. - New International PCT Patent Application for Scalable API Manufacturing
October 21, 2022
Albert Labs Files New International PCT Patent Application for scalable API manufacturing
October 20, 2022
Albert Labs Appoints Two Industry Leading Directors
July 11, 2022
Albert Labs Appoints Principal Investigator for Real World Evidence Study for KRN-101
May 26, 2022
Albert Labs Granted Health Canada Licence
May 16, 2022
Albert Labs Pre-Clinical Analytical And Toxicological Research Supports Company's Forthcoming Studies
May 13, 2022
Albert Labs' Pre-Clinical Analytical and Toxicological Research Supports Company's Forthcoming Studies
May 12, 2022
Albert Labs Announces the Addition of Two Renowned Scientific Advisors to its Scientific Advisory Board (SAB)
April 26, 2022
Albert Labs Files US Provisional Patent Application and Proves Out Consistent and Rapidly Scalable Production of Psilocybe and Other Mycelia
March 30, 2022